Physician profile
Maurizio A Miglietta
NPI 1710973243
$130,952.04
in general payments reported to CMS, 2019-2025
26 companies · $52K in 2025
The $52K reported for 2025 was more than what 99% of Surgical Critical Care providers received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $2,837 · 2021: $200 · 2022: $16K · 2023: $25K · 2024: $24K · 2025: $52K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $47K · Consulting Fee: $32K · Travel and Lodging: $11K · Food and Beverage: $6,960 · Education: $2,276 · Honoraria: $910 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $455.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $47,492.13 |
| Consulting Fee | $32,250.00 |
| Travel and Lodging | $11,267.93 |
| Food and Beverage | $6,960.46 |
| Education | $2,276.00 |
| Honoraria | $910.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $455.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $60,240.87 | 2019-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Tela Bio, INC. | $53,327.46 | 2021-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Intuitive Surgical, INC. | $11,287.61 | 2019-2024 | Da Vinci Surgical System |
| W. L. Gore & Associates, INC. | $2,093.35 | 2023 | Gore Bio-A Tissue Reinforcement |
| Cook Medical LLC | $670.32 | 2019 | |
| Davol INC. | $461.61 | 2023-2024 | Phasix Mesh |
| Smith+Nephew, INC. | $345.40 | 2019-2024 | Oasis, Collagenase Santyl, Allevyn Heel 10.5cm X 13.5cm Ctn 5 |
| Cook Incorporated | $338.33 | 2019 | |
| Amarin Pharma, INC. | $306.28 | 2019-2020 | |
| Baxter Healthcare | $271.19 | 2023-2024 | Floseal, Tisseel, Perclot |
| Medical Device Business Services, INC. | $197.89 | 2023-2024 | Matrixrib |
| Atricure, INC. | $183.77 | 2024 | |
| Zimmer Biomet Holdings, INC. | $148.33 | 2024 | Advantagerib |
| Ossdsign USA Incorporated | $133.94 | 2025 | Ossdsign Catalyst |
| Arteriocyte Medical Systems, INC. | $125.93 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $123.44 | 2019 | |
| Insmed, INC. | $117.00 | 2020 | |
| Musculoskeletal Transplant Foundation INC. | $115.28 | 2024 | |
| Conmed Corporation | $112.61 | 2024 | Airseal |
| Janssen Pharmaceuticals, INC | $112.51 | 2019 | |
| Hemosonics LLC | $96.75 | 2024 | Quantra Qplus System, Qunatra Qplus System |
| Astrazeneca Pharmaceuticals Lp | $50.32 | 2023-2024 | Andexxa |
| Integra Lifesciences Corporation | $28.64 | 2021 | |
| Olympus America INC. | $25.01 | 2024 | Olympus |
| Haemonetics Corporation | $21.42 | 2024 | Teg6s Hemostasis System |
| Osiris Therapeutics INC. | $16.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maurizio Miglietta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.